Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,916 Ovarian Cancer
clinical trials

Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University Hospital
mi
from
San Antonio, TX
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Santa Teresa-San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-San Marcos
mi
from
San Marcos, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Low Country Cancer Care Associates PC
mi
from
Savannah, GA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Francis Regional Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Springfield Regional Cancer Center
mi
from
Springfield, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Overlook Hospital
mi
from
Summit, NJ
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Tacoma/Valley Radiation Oncology Centers-Jackson Hall
mi
from
Tacoma, WA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Physicians LLC-Upper Valley
mi
from
Troy, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Legacy Meridian Park Hospital
mi
from
Tualatin, OR
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Medical Center - Vacaville
mi
from
Vacaville, CA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
MedStar Georgetown University Hospital
mi
from
Washington DC,
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC Washington Hospital Radiation Oncology
mi
from
Washington, PA
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Clinic - Wausau Center
mi
from
Wausau, WI
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Carmel St. Ann's
mi
from
Westerville, OH
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
SCL Health Lutheran Medical Center
mi
from
Wheat Ridge, CO
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Christiana Care Health System-Wilmington Hospital
mi
from
Wilmington, DE
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Southeastern Medical Oncology Center-Wilson
mi
from
Wilson, NC
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Status: Enrolling, Phase
Updated: 12/31/1969
Duke Cancer Institute
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating MM-310 in Patients With Solid Tumors
Status: Enrolling, Phase I
Updated: 11/29/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRa-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Ovarian Epithelial Cancer Clinical Trial
Safety and Efficacy Study of Daily SPL-108 Injections In Conjunction With Paclitaxel in Women With Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
UT Southwestern/Simmons Cancer Center-Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Oncology Clinical Trial
IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Malignant Neoplasm of Female Genital Organ Clinical Trial
Trial of Durvalumab (MEDI4736) and Tremelimumab Administered in Combination Versus Sequentially in Recurrent Platinum-Resistant Epithelial Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
MAGE-A4ᶜ¹º³²T for Multi-Tumor
Status: Enrolling, Phase I
Updated: 12/31/1969
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
MAGE-A4ᶜ¹º³²T for Multi-Tumor
Status: Enrolling, Phase I
Updated: 12/31/1969
Tennessee Oncology / Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
MAGE-A4ᶜ¹º³²T for Multi-Tumor
Status: Enrolling, Phase I
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
CAR T Cells in Mesothelin Expressing Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Carcinosarcoma, Ovarian Clinical Trial
Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Indiana University Health Melvin And Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Hyperthermic Intraperitoneal Chemotherapy or Intraperitoneal Chemotherapy in Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase II
Updated: 11/27/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Status: Enrolling, Phase I
Updated: 4/10/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project
Status: Enrolling
Updated: 10/25/2017
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling
Status: Enrolling
Updated: 12/31/1969
St Luke's Health System
mi
from
Kansas City, MO
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Is it Feasible?: Self-Affirmation for Hereditary Breast and Ovarian Cancer Genetic Counseling
Status: Enrolling
Updated: 12/31/1969
MedStar Health Institutions
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers, LLP;
mi
from
Lakewood, CO
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Arizona Oncology Associates, PC - HAL
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CDX-1140 as Monotherapy or in Combination in Patients With Advanced Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology, Reproductive Clinical Trial
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Ovarian Cancer Clinical Trial
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer (P204)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Virginia Cancer Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer (P204)
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer (P204)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer (P204)
Status: Enrolling, Phase II
Updated: 12/31/1969
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer (P204)
Status: Enrolling, Phase II
Updated: 12/31/1969
Stephenson Cancer Center University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Recurrent Platinum Resistant Ovarian Cancer Clinical Trial
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Recurrent Platinum Resistant Ovarian Cancer Clinical Trial
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
Status: Enrolling, Phase III
Updated: 12/31/1969
GHS Cancer Institute
mi
from
Greenville, SC
Click here to add this to my saved trials
Recurrent Platinum Resistant Ovarian Cancer Clinical Trial
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Recurrent Platinum Resistant Ovarian Cancer Clinical Trial
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlantic Health System Morristown Medical Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Baldwin Park
mi
from
Baldwin Park, CA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Strecker Cancer Center-Belpre
mi
from
Belpre, OH
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Bismarck Medical Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Boulder
mi
from
Boulder, CO
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
John H. Stroger, Jr. Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Good Samaritan Hospital - Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Midtown
mi
from
Denver, CO
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Broadlawns Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Genesys Hurley Cancer Institute
mi
from
Flint, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas - Fort Scott
mi
from
Fort Scott, KS
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
CHI Health Saint Francis
mi
from
Grand Island, NE
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
South Carolina Cancer Specialists
mi
from
Hilton Head Island, SC
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
First Dayton Cancer Care
mi
from
Kettering, OH
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Logan Regional Hospital
mi
from
Logan, UT
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers-Sky Ridge
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
McKee Medical Center
mi
from
Loveland, CO
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Holy Family Memorial Hospital
mi
from
Manitowoc, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marietta Memorial Hospital
mi
from
Marietta, OH
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Cancer Care-Milwaukee
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Clinic Minocqua Center
mi
from
Minocqua, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Knox Community Hospital
mi
from
Mount Vernon, OH
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Newton
mi
from
Newton, KS
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cancer Center of Kansas, PA - Pratt
mi
from
Pratt, KS
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Cancer Care-Racine
mi
from
Racine, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Clinic Rice Lake Center
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente Riverside
mi
from
Riverside, CA
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Endocrinology, Oncology, Reproductive Clinical Trial
Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Kaiser Permanente-San Diego Zion
mi
from
San Diego, CA
Click here to add this to my saved trials
1 … 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 … 69